Does PEMETREXED HEMIPENTAHYDRATE Cause Malignant neoplasm progression? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Malignant neoplasm progression have been filed in association with PEMETREXED HEMIPENTAHYDRATE (PEMRYDI RTU). This represents 13.2% of all adverse event reports for PEMETREXED HEMIPENTAHYDRATE.
9
Reports of Malignant neoplasm progression with PEMETREXED HEMIPENTAHYDRATE
13.2%
of all PEMETREXED HEMIPENTAHYDRATE reports
2
Deaths
1
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PEMETREXED HEMIPENTAHYDRATE?
Of the 9 reports, 2 (22.2%) resulted in death, 1 (11.1%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMETREXED HEMIPENTAHYDRATE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does PEMETREXED HEMIPENTAHYDRATE Cause?
Acquired gene mutation (7)
Pulmonary embolism (7)
Renal impairment (7)
Off label use (6)
Anaemia (5)
Death (5)
Diarrhoea (5)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)